ArticleTargeted oncology2010

Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice.

Yixiang Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.